Efficacy of Mifepristone - Prostaglandin Analogue Combination in Medical Termination of Pregnancy Beyond 7 Weeks of Amenorrhea

Trial Profile

Efficacy of Mifepristone - Prostaglandin Analogue Combination in Medical Termination of Pregnancy Beyond 7 Weeks of Amenorrhea

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Jul 2016

At a glance

  • Drugs Mifepristone (Primary)
  • Indications Induced abortion
  • Focus Therapeutic Use
  • Sponsors United Nordic Pharma
  • Most Recent Events

    • 06 Jul 2016 Status changed from recruiting to completed.
    • 01 Jun 2016 Planned End Date changed from 1 May 2016 to 1 Jul 2016.
    • 18 Apr 2016 Planned End Date changed from 1 Jul 2016 to 1 May 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top